doi: 10.5732/cjc.012.10184
Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
Lin Yang, Shi-Ying Yu, Guang-Yuan Hu
Oncology Center, Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, Hubei 430030, P. R. China
[Abstract] Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment.
Chinese Journal of Cancer 2013, Volume: 32, Issue 6, Page: 353-356
[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Lin Yang, Shi-Ying Yu, Guang-Yuan Hu. Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment. Chin J Cancer. 2013, 32(6):353-356. doi:10.5732/cjc.012.10184
Export citations
EndNote
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Lin Yang, Shi-Ying Yu, Guang-Yuan Hu. Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment. Chin J Cancer. 2013, 32(6):353-356. doi:10.5732/cjc.012.10184
Export citations
EndNote
SHARE THIS ARTICLE
Comments:
